Inside Geneva is at the World Health Assembly this week, finding out what lessons are being learned from Covid-19 now that the WHO says the global health emergency is over – even if the pandemic isn’t.
Suerie Moon, co-director, Global Health Centre, Geneva Graduate Institute said: "Every single country is vulnerable to pandemics. Every single country can have its economy, its society fundamentally undermined by a pandemic. We know this."
Member states are supposed to be working on a pandemic treaty – so we cope with the next one better. Fair access to medicines is a key issue.
Barbara Stocking, chair of panel for a global public health convention added: "On medicines and so on, I think this is the most difficult issue to be handling. I hope most countries are signed up to the view that there should be equity. I don’t think the developing countries will sign up to any treaty, when they don’t see that there are plans to get much nearer to equity."
Can medicine producers be persuaded to be generous?
Thomas Cueni, Director General, International Federation of Pharmaceutical Manufacturers (IFPMA) said: "You cannot coerce know how sharing, because either you’re willing to share your wisdom with me or you’re not. IP waivers, which means ignoring patents, would actually be a huge barrier."
Transparency and rapid information sharing are on the agenda too:
Imogen Foulkes, Inside Geneva host asked: "We still don’t know exactly how and where and from what Covid-19 came. Will we find that out do you think? Is investigation still going on?"
Maria van Kerkhove, World Health Organisation concluded: "We’re certainly going to do everything we can to figure out how this pandemic began. And it does depend on collaboration, scientific collaboration, collaboration from member states, sharing of information, sharing data, and we need more collaboration from China, we’ve been very vocal about that.’
Listen and subscribe to the podcast to find out more.
Get in touch!
Thank you for listening! If you like what we do, please leave a review.